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ABSTRACT
The mitochondrial genome encodes core catalytic peptides that affect major metabolic 
processes within a cell. Here, we investigated the association between mitochondrial DNA 
(mtDNA) variants and allergic diseases, including atopic dermatitis (AD) and asthma, 
alongside heteroplasmy within the mtDNA in subjects with allergic sensitization. We 
collected genotype data from 973 subjects with allergic sensitization, consisting of 632 
children with AD, 498 children with asthma, and 481 healthy controls by extracting DNA 
from their blood samples. Fisher's exact test was used to investigate mtDNA and nuclear 
DNA variants related to mitochondrial function (MT-nDNA) to identify their association with 
allergic diseases. Among the 69 mtDNA variants, rs28357671 located on the MT-ND6 gene 
displayed statistically significant associations with allergic diseases (Bonferroni-corrected P < 
7.25E-4), while 6, 4, and 2 genes were associated with allergic sensitization, AD, and asthma, 
respectively (P < 0.0002), including NLRX1, OCA2, and CHCHD3 among the MT-nDNA genes. 
Heteroplasmy of mitochondrial DNA associated with allergic sensitization was evaluated 
in a separate cohort of patients consisting of 59 subjects with allergic sensitization and 52 
controls. Heteroplasmy was verified when a patient carried both alleles of a mitochondrial 
single-nucleotide polymorphism (SNP) when clustered. One of the 134 mitochondrial SNPs 
showed heteroplasmy at a level of 0.4313 when clustering was applied. The probe sequence 
located at mitochondrial position 16217 and within the D-loop, which acts as a major 
control site for mtDNA expression. This is the first study to evaluate the association between 
mitochondrial DNA variants and allergic diseases. A harmonized effect of genes related to 
mitochondrial function may contribute to the risk of allergic diseases.
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INTRODUCTION
The mitochondrial genome encodes core catalytic peptides that form the major proteins of 
the electron transport chain. Associations between mitochondrial DNA (mtDNA) variants 
and metabolic traits, including body mass index and waist hip ratio, have recently been 
reported.1 Several studies have reported the connection between allergic diseases and 
metabolic conditions.2 Moreover, some studies have suggested a unifying mitochondrial 
link between these interlinked morbidities.3,4 Mitochondrial dysfunction occurs in allergic 
diseases, including both alteration in mitochondrial structure5 and function.6
Mitochondrial heteroplasmy is an important factor for many conditions, including 
neurological diseases7 and drug toxicities.8 Heteroplasmy is the mixed population of wild-type 
and mutated mtDNA within a cell, caused by potent oxygen free radicals and lack of protective 
histone proteins within the mitochondria.9 Since mutated and wild-type mtDNA can easily 
coexist in a single cell or a single sample, mtDNA variants can influence an individual's 
predisposition to complex diseases in a continuous manner through heteroplasmy.
Here, mtDNA and nuclear DNA variants related to mitochondrial function (MT-nDNA) were 
investigated to identify their associations with allergic diseases, including atopic dermatitis 
(AD) and asthma. We also looked into heteroplasmy within the mtDNA in subjects with 
allergic sensitization.
MATERIALS AND METHODS
Different cohorts were used to study the mtDNA/MT-nDNA variants and mitochondrial 
heteroplasmy. Each cohort and analysis are described as follows.
Identification of the mtDNA and MT-nDNA variant associations: cohort 
description
We collected genotype data from 973 subjects with known allergic sensitization and 481 
healthy controls to identify the mtDNA and MT-nDNA variants associated to allergic diseases. 
Subjects with allergic sensitization comprised 632 subjects with moderate-to-severe AD 
and 498 subjects with persistent asthma. Of these subjects, 475 had only AD, 341 had only 
asthma, and 157 had both. Allergic sensitization was defined by specific IgE levels of greater 
than 0.7 kUA/L to at least one of the following allergens: egg white, milk, peanut, soybean, 
wheat, Dermatophagoides pteronyssinus, Dermatophagoides farinae, Alternaria species, and Blattella 
germanica. AD was diagnosed by pediatric allergists (SCORing Atopic Dermatitis; SCORAD 
≥ 30) and asthma was confirmed on the basis of consistent respiratory symptoms verified by 
physicians. The presence of either a bronchodilator response of ≥12% increase in the forced 
expiratory volume in 1 second (FEV1), or bronchial hyperresponsiveness defined as a decrease 
in FEV1 of ≥20% with inhalation of <16 mg/mL methacholine was considered as asthma. 
Controls had neither allergic diseases nor allergic sensitization. Each subject provided 
written informed consent. The study was approved by the Institutional Review Board of 
Severance Hospital (Seoul, Korea; IRB No. 4-2004-0036).
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Identification of mtDNA and MT-nDNA variant associations: genotyping and 
analysis
DNA was extracted from blood samples of pediatric patients, and genome wide SNP and 
genetic variant information was sought by Illumina Human Core Exome 24 kit version 
1.0 (Illumina, Inc., San Diego, CA, USA). Since all subjects were Korean and unrelated, 
additional correction was not conducted. Subject ancestry evaluation was performed using 
GRAF-pop 2.3.110 to verify Asian descent in all subjects (Supplementary Fig. S1A). Kraja et al. 
1 provided a list of 2,282 nuclear genes that may contribute to mitochondria function. 
The “MT-nDNA candidates” were curated for their study using protein co-localization 
within the mitochondria and text mining. We used PLINK11 (http://pngu.mgh.harvard.
edu/purcell/plink/) to extract the mtDNA and MT-nDNA genes from the whole genome 
SNP data. Missingness per marker and per individual was set at under 0.05 and Hardy-
Weinbeg Equilibrium threshold was 0.0001. SNPs with a minor allele frequency over 0.01 
were included and Fisher's exact test was used to evaluate the associations. We evaluated 
mitochondrial gene-nuclear gene interactions by calculating the odds ratio considering both 
risk alleles of the mtDNA and MT-nDNA. Using the allele counting method for the risk allele 
in rs28357671 (MT-ND6) and each MT-nDNA, the total number of risk alleles present in the 
case and control groups were used to calculate the additive effect.
Investigating mitochondrial heteroplasmy: cohort description
Heteroplasmy associated with allergic sensitization was evaluated in a cohort of patients 
consisting 59 subjects with allergic sensitization and 52 controls. Allergic sensitization was 
confirmed using the same standards as before. All subjects were Korean and unrelated. Asian 
descent was confirmed in all subjects using GRAF-pop 2.3.110 (Supplementary Fig. S1B).
Investigating mitochondrial heteroplasmy: genotyping and analysis
We used genotype data from the Illumina Infinium Global Screening Array 24 kit on adult 
blood samples. Heteroplasmy occurs due to somatic mutation by environmental factors or 
errors made during DNA replication; thus, adults have accumulated more clinically relevant 
mtDNA mutations than children.12 The reliability of Illumina genotyping array data has been 
confirmed to estimate high level heteroplasmy and a method established to evaluate the 




Table 1 shows the subjects' characteristics consisting of 1,454 subjects for the mtDNA and 
MT-nDNA variant analysis and 111 subjects for mitochondrial heteroplasmy analysis. For 
the subjects in the mtDNA and MT-nDNA variant analysis, the mean age was 6.2 years for 
subjects with allergic sensitization, 4.8 years for those with AD, and 8.6 for those with 
asthma. Total serum immunoglobulin E (IgE) and blood eosinophil levels were much higher 
in subjects with allergic sensitization than in controls. However, the mean age for the 
mitochondrial heteroplasmy analysis was 45.5 years in subjects with allergic sensitization, 
focusing only on adult subjects.
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mtDNA and MT-nDNA variant associations
Among the 69 mtDNA genes remaining after QC, rs28357671 located on the mitochondrially 
encoded NADH:ubiquinone oxidoreductase core subunit 6 (MT-ND6) gene displayed a statistically 
significant association (Bonferroni-corrected P < 7.25E-4) with allergic sensitization, AD, and 
asthma (Table 2). rs28357671 showed more association with allergic sensitization (P = 3.84E-
07) than with AD (P = 3.03E-06) or asthma (P = 5.61E-05). The odds ratio (OR) for rs28357671 
was between 0.23 and 0.25 for the allele C. Among 2,282 MT-nDNA genes, 6, 4, and 2 were 
associated with allergic sensitization, AD, and asthma respectively (P < 0.0002) (Table 2).  
NLR family member X1 (NLRX1) and OCA2 melanosomal transmembrane protein (OCA2) were 
associated with both allergic sensitization and AD. Association to TAL bHLH transcription factor 
2 (TAL2), adaptor related protein complex 2 subunit beta 1 (AP2B1), Cbl proto-oncogene (CBL), and solute 
carrier family 2 member 1 (SLC2A1) were unique to allergic sensitization, while solute carrier family 
8 member A1 (SLC8A1) and family with sequence similarity 107 member B (FAM107B) were unique to 
AD. Coiled-coil-helix-coiled-coil-helix domain containing 3 (CHCHD3) was associated with asthma. 
Regarding mitochondrial gene-nuclear gene interactions, in half of the cases the interaction 
OR was greater than the MT-nDNA OR. rs4245191, which is located within the gene NLRX1, 
showed notable increases in OR for both allergic sensitization and atopic dermatitis with a 
difference of 0.377 and 0.396 respectively.
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Table 2. Mitochondrial variants and nuclear mitochondrial variants related to allergic diseases




P value OR Interaction 
OR†
mtDNA
Allergic sensitization rs28357671 MT-ND6 14178 T 0.98144 0.92516 3.84E-07 4.277
AD rs28357671 MT-ND6 14178 T 0.98254 0.92516 3.03E-06 4.552
Asthma rs28357671 MT-ND6 14178 T 0.97988 0.92516 5.61E-05 3.939
MT-nDNA
Allergic sensitization rs10816292 TAL2 9:108423366 T 0.4596 0.3826 0.000119 1.372 1.347
rs7179419 OCA2 15:28307179 G 0.3771 0.3044 0.000119 1.383 1.326
rs28384428 AP2B1 17:33913989 G 0.1881 0.132 0.000125 1.523 1.256
rs4245191 NLRX1 11:119052826 A 0.8832 0.8306 0.00013 1.542 1.919
rs6589722 CBL 11:119085783 T 0.8849 0.8326 0.000158 1.545 1.915
rs841852 SLC2A1 1:43401499 G 0.8443 0.7875 0.00018 1.463 1.757
AD rs4245191 NLRX1 11:119052826 A 0.8883 0.8306 0.000108 1.621 2.017
rs7179419 OCA2 15:28307179 G 0.3825 0.3044 0.000131 1.416 1.345
rs404005 SLC8A1 2:40396078 G 0.6463 0.5672 0.000178 1.394 1.489
rs11259210 FAM107B 10:14633723 A 0.6258 0.5468 0.000182 1.386 1.473
Asthma rs358734 C3orf33 3:155483319 C 0.5875 0.5011 0.000131 1.418 1.407
rs7808471 CHCHD3 7:132716502 C 0.1596 0.1021 0.000172 1.671 1.227
AD, atopic dermatitis; BP, base pair position; OR, odds ration; mtDNA, mitochondrial DNA; MT-nDNA, nuclear DNA variants related to mitochondrial function; 
SNP, single-nucleotide polymorphism.
*BP correspond to GRCh38/hg38 genome assembly; †Interaction OR is the odds ratio calculated by the additive effect of rs28357671 (MT-ND6) and each MT-nDNA SNP.
Table 1. Subject characteristics
Characteristics mtDNA variant associations Mitochondrial heteroplasmy
Allergic sensitization AD Asthma Control Allergic sensitization Control
No. subject 973 632 498 481 59 52
Age (yr) 6.2 ± 4.2 4.8 ± 4.2 8.6 ± 2.9 15.6 ± 10.7 45.5 ± 13.4 44.9 ± 15.0
Male sex 653 (67.1) 416 (65.8) 337 (67.7) 219 (45.5) 45 (76.3) 31 (59.2)
Total serum IgE (kU/L) 929.2 ± 1,130.0 1,054.0 ± 1,295.8 827.6 ± 877.2 40.7 ± 34.7 430.8 ± 689.2 24.1 ± 18.2
Blood eosinophils (/mm3) 807.0 ± 1,095.6 948.6 ± 1,314.1 578.0 ± 363.1 172.8 ± 135.0
SCORAD 53.9 ± 16.5
Data expressed as number (%) or mean ± standard deviation.
mtDNA, mitochondrial DNA; AD, atopic dermatitis; SCORAD, SCORing Atopic Dermatitis.
Mitochondrial heteroplasmy
Of the 134 mitochondrial SNP probes, only 1 showed heteroplasmy when clustering was 
applied to the genotype data (Figure). The probe sequence is located at mitochondrial 
position 16217 and is within the D-loop, which acts as a major control site for mtDNA 
expression, containing the leading-strand origin of replication and the major promoters 
for transcription.14 Out of all the 111 subjects studied, 108 had genotype data on the specific 
probe sequence. Of 91 individuals with genotype T, 45 (49%) exhibited allergic sensitization, 
while the remaining 46 (51%) did not. Furthermore, of 17 individuals with genotype C, 11 
(65%) exhibited allergic sensitization but 6 (35%) did not. The association between allergic 
sensitization and controls on heteroplasmy was not significant as revealed by Fisher's exact 
test (P = 0.2972). The individual with heteroplasmy was one exhibiting allergic sensitization 
with a heteroplasmy level of 0.4313.
DISCUSSION
Here, we found that rs28357671 is an mtDNA variant on the MT-ND6 gene and is highly 
associated with allergic diseases including AD and asthma. We also observed several nuclear 
genes that may contribute to mitochondrial function.
The C allele at rs28357671 was suggested to elicit a protective effect against allergic 
sensitization, although the case frequency and control frequency were fairly low. The 
MT-ND6 gene is a core subunit of the mitochondrial membrane respiratory chain NADH 
dehydrogenase. It functions in the transfer of electrons from NADH into the respiratory 
chain while coupling the flow of electrons to the pumping of protons. Although it has 
been studied in allergic diseases, there was a difference in expression levels in blood early 
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Figure. Clustering results for position 16217 on mtDNA genotype data. Polar coordinates display the cluster using 
the normalized theta and R values to denote the X and Y axis. Normalized theta represents the angle of deviation 
from the pure allele 1 signal, and normalized R represents the intensity of allele 2. 
mtDNA, mitochondrial DNA.
in Alzheimer's disease.15 All mtDNAs encode genes related to the process of oxidative 
phosphorylation, which ensues the production of mitochondrial reactive oxygen species 
(ROS).16 ROS promotes mitochondrial membrane transition pores or affects mitochondrial 
biogenesis, triggering proinflammatory action and tissue injury.17 In asthma, excess ROS in 
bronchial epithelial cells can cause airway hyper-responsiveness and epithelial cell damage.18 
An imbalance between mtDNAs, such as MT-ND6, may be involved in the derangement of 
oxidative phosphorylation and ATP production within cells, and might generate ROS.
Of the 2 MT-nDNA genes that are associated with allergic sensitization and AD, NLRX1 is 
localized in the mitochondria and amplifies nuclear factor-κB and JNK pathways by inducing 
ROS production. Suppression of NLRX1 was observed in chronic obstructive pulmonary 
disease, which has a substantial overlap with asthma with regard to its pathophysiological 
characteristics.19 Moreover, NLRX1 exhibited an increase in OR when its interaction with 
MT-ND6 was considered, implying ROS imbalance within the mitochondria by gene-
gene interactions. OCA2 is an integral membrane protein involved in tyrosine transport. 
Interestingly, tyrosine is related to various pathological mechanisms of AD, including the 
irregularly high expression of immunoreceptor tyrosine-based inhibitory motif domain 
on CD4+ T cells in AD patients.20 A combined effect of the MT-nDNA and mtDNA genes is 
expected to contribute in allergic sensitization and associated diseases.
CHCHD3, a nuclear gene encoding an inner mitochondrial membrane scaffold protein, 
was associated with asthma. CHCHD3 contributes to maintaining the integrity of crista 
which is a fold created by the mitochondrial inner membrane.21 It also engages in essential 
mitochondrial functions, including oxygen consumption and protein import. Reduced 
mitochondrial crista occurs in asthmatic airway remodeling in murine airway epithelium 
when observed through transmission electron microscopy.22,23 This suggests that CHCHD3 
mutation in asthmatic patients might be related to mitochondrial structural changes and 
dysfunction, such as ROS production and inflammation. Other genes that have not been 
mentioned are novel genes that lack previous research with regard to mitochondrial function 
and allergic diseases. Further research is needed to understand the effect of these variants.
The mitochondrial position 16217 has shown heteroplasmy in allergic sensitization subjects. 
This nucleotide position encodes multiple regulatory proteins and has association with 
endometriosis with regard to the identical nucleotide change, from T to C.24 It has been 
suggested that endometriosis is caused by oxidative stress by inducing an imbalance between 
ROS and antioxidants, leading to inflammatory responses. The underlying mechanism for 
allergic sensitization may be similar to that of endometriosis with respect to inflammation 
induction. Mitochondria resequencing arrays or mitochondria-targeted sequencing data are 
required in further studies to confirm the finding in other cohorts.
In conclusion, we identified MT-ND6, an mtDNA gene related to oxidative phosphorylation, 
which is highly associated with allergic diseases. MT-nDNA, such as NLRX1, OCA2, and 
CHCHD3, were also associated with AD, asthma, or allergic sensitization. Heteroplasmy was 
evaluated in subjects with allergic sensitization, and a patient was identified with a high level 
of heteroplasmy at an SNP in the displacement loop. Replication of mitochondrial genetic 
variants and a functional study to confirm mitochondrial dysfunction and ROS production 
in regard to genetic variants can further enhance the interpretation of our study. We pose 
the possibility of mtDNA variants leading to mitochondrial disruption or imbalance in 
ROS production, which induces inflammation in allergic diseases. This is the first study 
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to evaluate the association between mitochondrial DNA variants and allergic diseases. 
Considering the MT-nDNA candidates associated with allergic sensitization, a harmonized 
effect of genes related to mitochondrial function may contribute to the risk.
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Ancestry inference using GRAF-pop on the cohort for (A) mtDNA and MT-nDNA variant 
study (n = 1,454) and (B) mitochondrial heteroplasmy study (n = 135). The X and Y axis 
denotes the GDs calculated for ancestry inference. Subjects are primarily consisted of East 
Asian descent with less than 1% of other Asian descent.
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